NBC Weapons: Minutemen Get Warhead Transplant

Archives

:

NUCLEAR, BIOLOGICAL AND CHEMICAL WEAPONS

November 30, 2006: The United States has begun replacing W62 nuclear warheads, on 300 Minuteman III missiles, with refurbished W87 warheads. The W87 was originally built for the Peacekeeper missile, which carried ten W87s each. But the last Peacekeeper was retired last year. The W87 warheads were checked over and reconfigured to work on the Minuteman. The W62 is a 1960s design that does not have as many safety or reliability features as the W87, and is more expensive to maintain. The W87 is a 1980s design. Each Minuteman now carries one warhead, although it was designed to carry three. But the START II treaty restricts the missiles to one.

It took about $250 million to modify the W87s to work on Minuteman. One missile a week is being converted, so it will take over five years to complete the work. Both warheads contain a hydrogen (fusion) bomb. The W62s has a yield of 170 kilotons, the W87 is 300 kilotons. Both weapons, with their Re-entry Vehicle equipment, weigh about 800 pounds each.

 


Article Archive

NBC Weapons: Current 2022 2021 2020 2019 2018 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 1999 


X

ad
0
20

Help Keep Us Soaring

We need your help! Our subscription base has slowly been dwindling. We need your help in reversing that trend. We would like to add 20 new subscribers this month.

Each month we count on your subscriptions or contributions. You can support us in the following ways:

  1. Make sure you spread the word about us. Two ways to do that are to like us on Facebook and follow us on Twitter.
  2. Subscribe to our daily newsletter. We’ll send the news to your email box, and you don’t have to come to the site unless you want to read columns or see photos.
  3. You can contribute to the health of StrategyPage. A contribution is not a donation that you can deduct at tax time, but a form of crowdfunding. We store none of your information when you contribute..
Subscribe   Contribute   Close